These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 29327713)

  • 1. Expression of enhancer of zeste homolog 2 (EZH2) protein in histiocytic and dendritic cell neoplasms with evidence for p-ERK1/2-related, but not MYC- or p-STAT3-related cell signaling.
    Tian X; Xu J; Fletcher C; Hornick JL; Dorfman DM
    Mod Pathol; 2018 Apr; 31(4):553-561. PubMed ID: 29327713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of enhancer of zeste homolog 2 (EZH2) protein in small cell and aggressive B-cell non-Hodgkin lymphomas and differential regulation of EZH2 expression by p-ERK1/2 and MYC in aggressive B-cell lymphomas.
    Tian X; Pelton A; Shahsafaei A; Dorfman DM
    Mod Pathol; 2016 Sep; 29(9):1050-7. PubMed ID: 27282353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of Combined EZH2, p-ERK1/2, p-STAT, and MYC Expression in the Differential Diagnosis of EZH2-positive Hodgkin Lymphomas and Related Large B-Cell Lymphomas.
    Tian X; Xu J; Dorfman DM
    Am J Surg Pathol; 2019 Jan; 43(1):102-109. PubMed ID: 30371509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High frequency of clonal IG and T-cell receptor gene rearrangements in histiocytic and dendritic cell neoplasms.
    Huang W; Qiu T; Zeng L; Zheng B; Ying J; Feng X
    Oncotarget; 2016 Nov; 7(48):78355-78362. PubMed ID: 27823979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancer of zeste homolog 2 is widely expressed in T-cell neoplasms, is associated with high proliferation rate and correlates with MYC and pSTAT3 expression in a subset of cases.
    Shi M; Shahsafaei A; Liu C; Yu H; Dorfman DM
    Leuk Lymphoma; 2015 Jul; 56(7):2087-91. PubMed ID: 25263318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The phosphatidylserine receptors, T cell immunoglobulin mucin proteins 3 and 4, are markers of histiocytic sarcoma and other histiocytic and dendritic cell neoplasms.
    Dorfman DM; Hornick JL; Shahsafaei A; Freeman GJ
    Hum Pathol; 2010 Oct; 41(10):1486-94. PubMed ID: 20656318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of Ezh2 Upregulates Gfi1 and Drives Aggressive Myc-Driven Group 3 Medulloblastoma.
    Vo BT; Li C; Morgan MA; Theurillat I; Finkelstein D; Wright S; Hyle J; Smith SMC; Fan Y; Wang YD; Wu G; Orr BA; Northcott PA; Shilatifard A; Sherr CJ; Roussel MF
    Cell Rep; 2017 Mar; 18(12):2907-2917. PubMed ID: 28329683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histiocytic and Dendritic Cell Sarcomas of Hematopoietic Origin Share Targetable Genomic Alterations Distinct from Follicular Dendritic Cell Sarcoma.
    Massoth LR; Hung YP; Ferry JA; Hasserjian RP; Nardi V; Nielsen GP; Sadigh S; Venkataraman V; Selig M; Friedmann AM; Samore W; Killian JK; Milante R; Giessinger J; Foley-Peres K; Marcus C; Severson E; Duncan D; Sivakumar S; Ross JS; Desphande V; Ramkissoon SH; Vergilio JA; Louissaint A; Zukerberg LR; Williams EA
    Oncologist; 2021 Jul; 26(7):e1263-e1272. PubMed ID: 33904632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histiocytic and dendritic neoplasms.
    Skoog L; Tani E
    Monogr Clin Cytol; 2009; 18():56-9. PubMed ID: 19092263
    [No Abstract]   [Full Text] [Related]  

  • 10. JNK and STAT3 signaling pathways converge on Akt-mediated phosphorylation of EZH2 in bronchial epithelial cells induced by arsenic.
    Chen B; Liu J; Chang Q; Beezhold K; Lu Y; Chen F
    Cell Cycle; 2013 Jan; 12(1):112-21. PubMed ID: 23255093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells.
    Kim E; Kim M; Woo DH; Shin Y; Shin J; Chang N; Oh YT; Kim H; Rheey J; Nakano I; Lee C; Joo KM; Rich JN; Nam DH; Lee J
    Cancer Cell; 2013 Jun; 23(6):839-52. PubMed ID: 23684459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of Enhancer of Zeste Homolog 2 (EZH2) with Associated pERK Co-Expression and PRC2 Complex Protein SUZ12 Correlation in Adult T-Cell Leukemia/Lymphoma.
    Chai J; Choudhuri J; Gong JZ; Wang Y; Tian X
    Cancers (Basel); 2024 Feb; 16(3):. PubMed ID: 38339397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hsp90α Mediates BMI1 Expression in Breast Cancer Stem/Progenitor Cells through Facilitating Nuclear Translocation of c-Myc and EZH2.
    Lee YC; Chang WW; Chen YY; Tsai YH; Chou YH; Tseng HC; Chen HL; Wu CC; Chang-Chien J; Lee HT; Yang HF; Wang BY
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28914785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EZH2 inhibition in multiple myeloma downregulates myeloma associated oncogenes and upregulates microRNAs with potential tumor suppressor functions.
    Alzrigat M; Párraga AA; Agarwal P; Zureigat H; Österborg A; Nahi H; Ma A; Jin J; Nilsson K; Öberg F; Kalushkova A; Jernberg-Wiklund H
    Oncotarget; 2017 Feb; 8(6):10213-10224. PubMed ID: 28052011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Descriptive Analysis of Histiocytic and Dendritic Cell Neoplasms: A Single-Institution Experience.
    Kim HM; Yang WI; Lyu CJ; Hahn SM; Yoon SO
    Yonsei Med J; 2020 Sep; 61(9):774-779. PubMed ID: 32882761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyploid giant cancer cells, EZH2 and Myc upregulation in mammary epithelial cells infected with high-risk human cytomegalovirus.
    Nehme Z; Pasquereau S; Haidar Ahmad S; El Baba R; Herbein G
    EBioMedicine; 2022 Jun; 80():104056. PubMed ID: 35596973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EZH2 promotes invasion and tumour glycolysis by regulating STAT3 and FoxO1 signalling in human OSCC cells.
    Zheng M; Cao MX; Luo XJ; Li L; Wang K; Wang SS; Wang HF; Tang YJ; Tang YL; Liang XH
    J Cell Mol Med; 2019 Oct; 23(10):6942-6954. PubMed ID: 31368152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reactive and neoplastic histiocytic diseases in the dog].
    Schwens Ch; Thom N; Moritz A
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2011; 39(3):176-90. PubMed ID: 22143627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity.
    Özeş AR; Pulliam N; Ertosun MG; Yılmaz Ö; Tang J; Çopuroğlu E; Matei D; Özeş ON; Nephew KP
    Oncogene; 2018 Jun; 37(26):3589-3600. PubMed ID: 29576612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of EZH2 suppresses peritoneal angiogenesis by targeting a VEGFR2/ERK1/2/HIF-1α-dependent signaling pathway.
    Shi Y; Li J; Chen H; Hu Y; Tang L; Wang Y; Zang X; Ma X; Huang G; Zhou X; Tao M; Lv Z; Chen S; Qiu A; Zhuang S; Liu N
    J Pathol; 2022 Oct; 258(2):164-178. PubMed ID: 35792675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.